Skip to content

Urolithiasis (Kalladaippu)- An oral administration of siddha drug Samsakra Chooranam

A Prospective Open Labelled single arm non-randomized single Centric phase II clinical trial to determine the effectiveness of Samsakra Chooranam in the management of Kalladaippu (Urolithiasis) - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/086014
Enrollment
40
Registered
2025-04-30
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N209- Urinary calculus, unspecified

Interventions

Intervention1: Samsakra chooranam: Dosage:3g twice a day orally for 40 days Control Intervention1: Nil: Nil

Sponsors

Government Siddha Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Evidence of renal calculus confirmed by USG Renal colicky pain (loin to groin pain) Nausea, vomiting, sweating Haematuria Oliguria Dysuria Patients who are willing to undergo radiological investigation and give blood for laboratory investigation.

Exclusion criteria

Exclusion criteria: Age: Below 20years and Above 61 years Chronic appendicitis Pregnancy and lactation Chronic kidney disease Bilateral obstructive neuropathy Pelvic inflammatory disease Diabetes mellitus Metabolic disorders like hyperthyroidism, hypothyroidism, hyperparathyroidism.

Design outcomes

Primary

MeasureTime frame
The outcome will be aimed at reducing the symptoms of Kalladaippu(Urolithiasis) and the kidney stone is expelled to come out or be disintegrated and mixed with urine will be ensured and to determine the therapeutic efficacy of clinical trial drug(Samsakra chooranam)Timepoint: 40 days

Secondary

MeasureTime frame
The secondary outcome is reduction in size of the kidney stone in USG abdomen and pelvisTimepoint: 40 days

Countries

India

Contacts

Public ContactProf Dr T Komalavalli Alias Mehala

Government Siddha Medical College and Hospital

komalaarumugam1@gmail.com9788122691

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026